Metabolic homeostasis as the cornerstone of aging;L'Homéostasie métabolique au cœur du vieillissement

Medecine/Sciences

Volumn 28, Issue 3, 2012, Pages 311-315

  Terret, Catherine ^a   Solari, Florence ^b,c,d  

^a CENTRE LÉON BÉRARD   (France)

^b UNIVERSITÉ LYON 1   (France)

^c CENTRE DE RECHERCHE EN CANCÉROLOGIE DE LYON   (France)

^d CENTRE DE GÉNÉTIQUE MOLÉCULAIRE ET CELLULAIRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CAENORHABDITIS ELEGANS PROTEIN; CARRIER PROTEIN; INSULIN; PROTEIN KINASE; RESVERATROL; SLCF 1 PROTEIN, C ELEGANS; SLCF-1 PROTEIN, C ELEGANS; SOMATOMEDIN C; STILBENE DERIVATIVE; TARGET OF RAPAMYCIN KINASE;

AGING; ANIMAL; BIOLOGICAL MODEL; CAENORHABDITIS ELEGANS; CALORIC RESTRICTION; CELL TRANSFORMATION; DROSOPHILA MELANOGASTER; ENERGY METABOLISM; GENETICS; HOMEOSTASIS; HUMAN; LONGEVITY; METABOLISM; MOUSE; NEOPLASM; PHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION;

AGING; ANIMALS; CAENORHABDITIS ELEGANS; CAENORHABDITIS ELEGANS PROTEINS; CALORIC RESTRICTION; CELL TRANSFORMATION, NEOPLASTIC; DROSOPHILA MELANOGASTER; ENERGY METABOLISM; HOMEOSTASIS; HUMANS; INSULIN; INSULIN-LIKE GROWTH FACTOR I; LONGEVITY; MEMBRANE TRANSPORT PROTEINS; MICE; MODELS, BIOLOGICAL; NEOPLASMS; PROTEIN KINASES; SIGNAL TRANSDUCTION; STILBENES; TOR SERINE-THREONINE KINASES;

EID: 84860817542     PISSN: 07670974     EISSN: 19585381     Source Type: Journal    
DOI: 10.1051/medsci/2012283020     Document Type: Review

References (40)

1. Johnson TE. Increased life-span of age-1 mutants in Caenorhabditis elegans and lower Gompertz rate of aging. Science 1990;249:908-12.
2. Kenyon C, Chang J, Gensch E, et al. A C. elegans mutant that lives twice as long as wild type. Nature 1993;366:461-4. (Pubitemid 24013878)
3. Blüher M, Kahn BB, Kahn CR. Extended longevity in mice lacking the insulin receptor in adipose tissue. Science 2003;299:572-4. (Pubitemid 36135156)
4. Holzenberger M, Dupont J, Ducos B, et al. IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice. Nature 2003;421:182-7. (Pubitemid 36090987)
5. Garofalo RS. Genetic analysis of insulin signaling in Drosophila. Trends Endocrinol Metab 2002;13:156-62. (Pubitemid 36733989)
6. Wolkow CA, Kimura KD, Lee MS, Ruvkun G. Regulation of C. elegans life-span by insulinlike signaling in the nervous system. Science 2000;290:147-50.
7. Hwangbo DS, Gershman B, Gersham B, et al. Drosophila dFOXO controls lifespan and regulates insulin signalling in brain and fat body. Nature 2004;429:562-6. (Pubitemid 38737660)
8. Kappeler L, De Magalhaes Filho C, Dupont J, et al. Brain IGF-1 receptors control mammalian growth and lifespan through a neuroendocrine mechanism. PLoS Biol 2008;6:e254.
9. Kapahi P, Chen D, Rogers AN, et al. With TOR, less is more: a key role for the conserved nutrientsensing TOR pathway in aging. Cell Metab 2010;11:453-65.
10. McCay CM, Maynard LA. The effect of retarded growth upon the length of life span and upon the ultimate body size. Nutrition 1935;5:155-72.
11. Colman RJ, Anderson RM, Johnson SC, et al. Caloric Restriction delays disease onset and mortality in Rhesus monkeys. Science 2009;325:201-4.
12. Mair W, Dillin A. Aging and survival: the genetics of life span extension by dietary restriction. Annu Rev Biochem 2008;77:727-54.
13. Piper M D W, Bartke A. Diet and aging. Cell Metab 2008;8:99-104.
14. Panowski SH, Wolff S, Aguilaniu H, et al. PHA-4/Foxa mediates dietrestriction-induced longevity of C. elegans. Nature 2007;447:550-5. (Pubitemid 46868041)
15. Bonkowski MS, Rocha JS, Masternak MM, et al. Targeted disruption of growth hormone receptor interferes with the beneficial actions of calorie restriction. Proc Natl Acad Sci USA 2006;103:7901-5.
16. Liao CY, Rikke BA, Johnson TE, et al. Genetic variation in the murine lifespan response to dietary restriction: from life extension to life shortening. Aging Cell; 9:92-5.
17. Greer EL, Dowlatshahi D, Banko MR, et al. An AMPK-FOXO pathway mediates longevity induced by a novel method of dietary restriction in C. elegans. Curr Biol 2007;17:1646-56. (Pubitemid 47503807)
18. Bordone L, Cohen D, Robinson A, et al. SIRT1 transgenic mice show phenotypes resembling calorie restriction. Aging Cell 2007;6:759-67. (Pubitemid 350131044)
19. Harrison DE, Strong R, Sharp ZD, et al. Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature 2009;460:392-5.
20. Cuervo AM, Wong ES, Martinez-Vicente M. Protein degradation, aggregation, and misfolding. Mov Disord 2010;25(suppl 1):S49-54.
21. Lopez-Lluch G, Hunt N, Jones B, et al. Calorie restriction induces mitochondrial biogenesis and bioenergetic efficiency. Proc Natl Acad Sci USA 2006;103:1768-73. (Pubitemid 43228768)
22. Qiu X, Brown K, Hirschey MD, et al. Calorie restriction reduces oxidative stress by SIRT3-mediated SOD2 activation. Cell Metab 2010;12:662-7.
23. Bishop NA, Guarente L. Two neurons mediate diet-restriction-induced longevity in C. elegans. Nature 2007;447:545-9. (Pubitemid 46868049)
24. Steinkraus KA, Smith ED, Davis C, et al. Dietary restriction suppresses proteotoxicity and enhances longevity by an hsf-1-dependent mechanism in Caenorhabditis elegans. Aging Cell 2008;7:394-404. (Pubitemid 351663908)
25. Chen D, Thomas EL, Kapahi P. HIF-1 modulates dietary restriction-mediated lifespan extension via IRE-1 in Caenorhabditis elegans. PLoS Genet 2009;5:e1000486.
26. Weindruch R, Walford RL. Dietary restriction in mice beginning at 1 year of age: effect on life-span and spontaneous cancer incidence. Science 1982;215:1415-8. (Pubitemid 12129729)
27. Solari F, Bourbon-Piffaut A, Masse I, et al. The human tumour suppressor PTEN regulates longevity and dauer formation in Caenorhabditis elegans. Oncogene 2005;24:20-7. (Pubitemid 40143861)
28. Masse I, Molin L, Mouchiroud L, et al. A novel role for the SMG-1 kinase in lifespan and oxidative stress resistance in Caenorhabditis elegans. PLoS One 2008;3:e3354.
29. Mouchiroud L, Molin L, Kasturi P, et al. Pyruvate imbalance mediates metabolic reprogramming and mimics lifespan extension by dietary restriction in Caenorhabditis elegans. Aging Cell 2011;10:39-54.
30. Kalaany NY, Sabatini DM. Tumours with PI3K activation are resistant to dietary restriction. Nature 2009;458:725-31.
31. Pelicano H, Carney D, Huang P. ROS stress in cancer cells and therapeutic implications. Drug Resist Updat 2004;7:97-110. (Pubitemid 38736063)
32. Fontana L, Partridge L, Longo VD. Extending healthy life span: from yeast to humans. Science 2010;328:321-6.
33. Mouchiroud L, Molin L, Dalliere N, Solari F. Life span extension by resveratrol, rapamycin, and metformin: the promise of dietary restriction mimetics for an healthy aging. Biofactors 2010;36:377-82.
34. Zask A, Verheijen JC, Richard DJ. Recent advances in the discovery of smallmolecule ATP competitive mTOR inhibitors: a patent review. Expert Opin Ther Pat 2011;21:1109-27.
35. Belda-Iniesta C, Pernia O, Simo R. Metformin: a new option in cancer treatment. Clin Transl Oncol 2011;13:363-7.
36. McClean PL, Parthsarathy V, Faivre E, Holscher C. The diabetes drug liraglutide prevents degenerative processes in a mouse model of Alzheimer's disease. J Neurosci 2011;31:6587-94.
37. Cohen E, Paulsson JF, Blinder P, et al. Reduced IGF-1 signaling delays age-associated proteotoxicity in mice. Cell 2009;139:1157-69.
38. Brunet A. Bien vieillir: la voie de signalisation insuline-FOXO et la longévité. Med Sci (Paris) 2012;28:316-20.
39. Pallet N, Beaune P, Thervet E, Legendre C, Anglicheau D. Inhibiteurs des mTOR: des antiprolifératifs pléiotropiques. Med Sci (Paris) 2006;22:947-52.
40. Foretz M, Guigas B, Viollet B. Du cancer au traitement du diabète: le suppresseur de tumeur LKB1 comme nouvelle cible pharmacologique. Med Sci (Paris) 2006;22:348-50.